Latkin Jed 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 7, 2020
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Award
Stock Option
2020-02-06$0.00/sh+100,000$100→ 203,250 totalExercise: $1.06Exp: 2030-02-06→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Stock options will vest one-third on each of the first three anniversaries of the date of grant.